Health-tech startup Iom Bioworks has raised ₹4 crore in a seed funding round led by Inflection Point Ventures (IPV), with participation from other strategic investors.
The funds will be used to strengthen marketing, secure intellectual property, scale up core infrastructure, and expand both scientific and commercial teams.
Founded in 2022 by Bipin Pradeep Kumar, Dr. Samik Ghosh, and Dr. Hiroaki Kitano, Iom Bioworks is advancing personalized healthcare by therapeutically modulating key gut bacteria to enhance human health and well-being.
Its proprietary platform uses artificial intelligence and large-scale biological network mapping to deliver food and prebiotic recommendations tailored to individual microbiomes.
Also Read | Kisah Apparels Raises Rs 13 Crore in Pre-Series A Funding Round
In its first year, Iom Bioworks served over 500 customers, secured two patents (with two more in progress), and published research in leading scientific journals. It offers a fully digital platform, with at-home gut profiling kits and personalized wellness plans, and operates a pan-India logistics network.
The startup is headquartered in Bengaluru and is actively expanding its capabilities in personalized microbiome-driven healthcare as it looks to become a category leader in India’s growing wellness and diagnostics market.
